Respiratory Therapeutics Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Respiratory Therapeutics Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Pneumonia
Researchers at Kuwait University, Medical Department publish new data on pneumonia
September 7th, 2009
According to recent research from Kuwait, "The Enterobacteriaceae, especially Escherichia coli and Klebsiella spp., as well as Acinetobacter spp., are important agents of nosocomial infections in hospitalized patients. A total of 460 Gram-negative bacteria (GNB), were investigated for their susceptibility to tigecycline and 9 other antibiotics by the Etest." "ESBL production was inferred from ESBL Etest phenotypes. All the GNB, including the ESBL-producers, were susceptible to tigecycline with MIC90 ranges of 0.25 to 2 mu g/ml. Imipenem and meropenem were very active against ESBL and non-ESBL producers; mean MIC(90)s of 0.19 and 0.09 mu g/ml and 0.05 mu g/ml and 0.02 mu...
Source: Respiratory Therapeutics Week (2009-09-07)
|
